Core Insights - Investors in the Medical - Dental Supplies sector may consider Labcorp (LH) or Align Technology (ALGN) for potential undervalued stock opportunities [1] Group 1: Zacks Rank and Earnings Outlook - Labcorp has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Align Technology has a Zacks Rank of 4 (Sell) [3] - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, suggesting that Labcorp's earnings outlook is improving more significantly than Align Technology's [3][7] Group 2: Valuation Metrics - Labcorp has a forward P/E ratio of 15.57, compared to Align Technology's forward P/E of 22.40 [5] - Labcorp's PEG ratio is 1.85, while Align Technology's PEG ratio is significantly higher at 3.97, indicating that Labcorp may be undervalued relative to its expected earnings growth [5] - Labcorp's P/B ratio is 2.54, whereas Align Technology's P/B ratio is 4.28, further supporting Labcorp's position as a more attractive value option [6] Group 3: Value Grades - Based on various valuation metrics, Labcorp holds a Value grade of B, while Align Technology has a Value grade of D, reinforcing Labcorp's superior value proposition [6]

Align Technology (ALGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 5, 2025, might help the stock move higher if these key numbers are bette ...

Align Technology, Inc. (ALGN) is set to release fourth-quarter 2024 results on Feb. 5, after the closing bell.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The company posted adjusted earnings per share (EPS) of $2.35 in the last reported quarter, which topped the Zacks Consensus Estimate by 1.7%. Align Technology beat on earnings in each of the trailing four quarters, the average surprise being 6.18%.ALGN’s Q4 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $997.0 m ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Align Technology (ALGN) , which belongs to the Zacks Medical - Dental Supplies industry.This maker of the Invisalign tooth-straightening system has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 2.81%.For the most recent quarter, Align Technology was exp ...

For Align Technology (ALGN) , we remain concerned about the current economic uncertainty, which continues to cast a negative impact on the company’s dental procedures. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.Factors Dragging ALGN Shares DownIn recent times, Align Technology has faced a decline in Invisalign's average selling price (ASP) for comprehensive treatment options. This resulted in a decrease in the company’s revenues. In the second quar ...

The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term upside. The bull case remains firmly in place even after the stock market’s best back-to-back years since the late 1990s.That said, the market appears a tad overheated heading into Q4 earnings season next week. There could be some selling pressure to recalibrate valuations and take some of the foam off the top of the market.Despite tech and broader market valuations looking a bit stretch ...

Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.Align Technology — a medical device company that manufactures and sells dental aligners, scanners, and software for digital orthodontics and restorative dentistry — will benefit from improving consumer sentiment, easing comps and continued equipment traction with Lumina.In October, Align Technology announced that it is planning to repurchase $275 million of its common s ...

Company Performance - Shares of Align Technology (NASDAQ: ALGN), the market leader in clear aligners, have fallen more than 20% over the past year due to slowing growth in a tough macroeconomic environment where discretionary spending by consumers has been impacted [1] Analyst Background - The analyst is an individual investor with a focus on undercovered companies, particularly in technology, software, electronics, and the energy transition sectors [1] - The analyst has over 7 years of personal investing experience and a Masters degree in Electrical Engineering, currently working as an automotive battery R&D engineer in Sweden [1] - The analyst enjoys researching small to mid-cap companies that are often less covered by others, aiming to identify asymmetric investment opportunities for market-beating returns [1]

Core Insights - Align Technologies is well-positioned for growth due to the robust potential of Invisalign and strategic expansions [1][3] - The company has a market capitalization of $15.94 billion and has consistently surpassed earnings estimates [2] - The malocclusion market presents a significant opportunity for Align Technologies, with only 22 million people globally opting for orthodontic treatment annually, indicating a large untapped patient base [3] Financial Performance - In the third quarter, Align Technologies reported a 15.6% increase in Systems and Services revenues, driven by higher scanner average selling prices (ASPs) and increased service revenues [6] - Clear Aligner volume reached 617,000, reflecting a 2.5% year-over-year increase, with growth noted across all regions [12] - The Zacks Consensus Estimate for the company's 2024 revenues is projected at $4.04 billion, suggesting a 4.6% increase from the previous year [17] Market Dynamics - The company faces macroeconomic challenges, including staffing shortages and supply chain issues, which are impacting revenues and margins [7] - Adverse currency impacts are a concern, particularly due to a significant portion of revenues coming from international markets, affecting Clear Aligner ASPs [16] Strategic Initiatives - Align Technologies is focusing on strategic alliances with dental support organizations (DSOs) to drive the adoption of digital dentistry, particularly targeting young adults and teens through influencer partnerships [13] - The iTero intraoral scanners and exocad CAD/CAM software are expanding their market presence, with the launch of the next-generation iTero Lumina scanner [14]

Align Technology's (ALGN) dental procedures continue to be affected by the current economic uncertainty. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.Factors Dragging ALGN Shares DownThe ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting revenues and margins for Align Technology. Deteriorating international trade, with global inflationary pressure leading to a tough situation related to raw material and labo ...